首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Central nervous system agents in medicinal chemistry

缩写:

ISSN:1871-5249

e-ISSN:1875-6166

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引475
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sonia Singh Sonia Singh
Nutraceuticals obtained from natural sources have been explored as well as studied for significant applications to treat several diseases like diabetes, cardiovascular diseases, and neurodegenerative diseases. The manuscript explores the mo...
Bhawna Shridhar,Jatin Kishore Sharma,Akhlesh Kumari et al. Bhawna Shridhar et al.
Introduction: Neurological disorders impair cognitive, emotional, and behavioural functions, leading to a reduced quality of life. Due to the limitations of conventional therapies, the present study aimed to develop and e...
Divya Aggarwal,Nitesh Malhotra,Pooja Sharma et al. Divya Aggarwal et al.
Introduction: The progressive neurodegenerative disease known as Parkinson's Disease (PD) is represented by deficits in both motor and non-motor functions. Levodopa and dopamine agonists are examples of pharmaceutical tre...
Jayaramakani Natarajan,Srinivasan Ranganathan Jayaramakani Natarajan
Hydrogel-Forming Microneedles (HFMNs) offer a minimally invasive, patient-friendly, and sustained-release platform for transdermal delivery. By swelling upon insertion to form a hydrogel matrix, they enable efficient delivery of small molec...
Madan Mohan Agrawal,Payal Mittal Madan Mohan Agrawal
Alzheimer's disease, an extremely prevalent neurological illness and the leading cause of dementia globally, is an extremely prevalent neurological illness and is the leading cause of dementia globally. There are a few treatment options for...
Indrakumar Subramanian,Remya Ramachandran Surajambika,Dibenthiran Sekar et al. Indrakumar Subramanian et al.
Introduction: Neurodegenerative disorders, including Alzheimer's, Parkinson's, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease, are characterized by progressive neuronal loss driven by damage o...
Felix-Martin Werner,Rafael Coveñas Felix-Martin Werner
Introduction: Schizophrenia and schizoaffective disorder are generally treated with second- generation antipsychotic drugs. These drugs are mostly dopaminergic (D2) and serotonergic (5-HT2A) antagonists. They sufficiently...
Karen Alejandra González-Jiménez,Elsa Verónica Herrera-Mayorga,Francisco Alejandro Paredes Sánchez et al. Karen Alejandra González-Jiménez et al.
Neurodegenerative diseases encompass well-characterized behavioral, cognitive, and movement disorders that affect older people, impacting all facets of daily life. In Alzheimer's disease, specific antibodies targeting the β-amyloid protein...
Radha Agrawal,Yogesh Murti,Mohit Mangla et al. Radha Agrawal et al.
Introduction: Tuberculosis (TB) is the most common disease that affects the lungs, and it is associated with Mycobacterium tuberculosis infection. Many synthetic medications, such as pyrazinamide, isoniazid, and ethambuto...
Nitika Garg,Sanchit Dhankhar,Ankush Dhariya et al. Nitika Garg et al.
The complex etiology and limited therapy options of neurodegenerative illnesses pose daunting challenges to modern medicine. Nonetheless, novel treatment approaches have exciting new possibilities because of developments in nanotechnology. ...